| Dr F Tom Peterson, EDD LICENSE PSYCHOLO | |
|
18 N 8th Street, #3, Miles City, MT 59301-0176 | |
| (406) 232-1595 | |
| (406) 232-1595 |
| Full Name | Dr F Tom Peterson |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 53 Years |
| Location | 18 N 8th Street, Miles City, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033295712 | NPI | - | NPPES |
| 493389 | Medicaid | MT | |
| 5053 | Other | MT | BLUE SHIELD/BC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 119 (Montana) | Primary |
| Entity Name | Peterson Psychological Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679812937 PECOS PAC ID: 3274765250 Enrollment ID: O20140404001276 |
News Archive
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
Janssen Research & Development, LLC announced data from the Phase 3 multicenter study SAR3007, which demonstrated a significant improvement in progression-free survival with trabectedin (YONDELIS®) compared to dacarbazine in patients with advanced liposarcoma (LPS) or leiomyosarcoma (LMS) previously treated with an anthracycline and at least one additional chemotherapy regimen.
Small is beautiful in the medical world. And being able to give European industry the edge in a nearly €200 billion worldwide biomedical market is what drives a consortium of EU-backed partners to make and market smaller, cheaper and better biomedical devices and innovative new applications.
A new commercial processing technology is suitable for boosting the vitamin D content of mushrooms and has no adverse effects on other nutrients in those tasty delicacies, the first study on the topic has concluded. The technology, which involves exposing mushrooms to the same kind of ultraviolet light that produces suntans, can greatly boost mushrooms' vitamin D content. It appears in ACS' Journal of Agricultural and Food Chemistry.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr F Tom Peterson, EDD LICENSE PSYCHOLO Po Box 176, Peterson Psychological Services, Miles City, MT 59301-0176 Ph: (406) 232-1595 | Dr F Tom Peterson, EDD LICENSE PSYCHOLO 18 N 8th Street, #3, Miles City, MT 59301-0176 Ph: (406) 232-1595 |
News Archive
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
Janssen Research & Development, LLC announced data from the Phase 3 multicenter study SAR3007, which demonstrated a significant improvement in progression-free survival with trabectedin (YONDELIS®) compared to dacarbazine in patients with advanced liposarcoma (LPS) or leiomyosarcoma (LMS) previously treated with an anthracycline and at least one additional chemotherapy regimen.
Small is beautiful in the medical world. And being able to give European industry the edge in a nearly €200 billion worldwide biomedical market is what drives a consortium of EU-backed partners to make and market smaller, cheaper and better biomedical devices and innovative new applications.
A new commercial processing technology is suitable for boosting the vitamin D content of mushrooms and has no adverse effects on other nutrients in those tasty delicacies, the first study on the topic has concluded. The technology, which involves exposing mushrooms to the same kind of ultraviolet light that produces suntans, can greatly boost mushrooms' vitamin D content. It appears in ACS' Journal of Agricultural and Food Chemistry.
› Verified 8 days ago
Dr. Susan Oleta Mattocks, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 2600 Wilson St, Suite 2, Miles City, MT 59301 Phone: 406-233-4219 Fax: 406-233-2503 |